Michael Dacks

Michael Dacks

Founder chez Type 2 Ventures Ltd.

47 ans
Process Industries
Consumer Services
Health Technology

Profil

Michael Dacks is the founder of Midatadin.com Ltd.
(founded in 2013) and Type 2 Ventures Ltd.
(founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Postes actifs de Michael Dacks

SociétésPosteDébut
Type 2 Ventures Ltd. Founder 01/04/2019
Psyence Therapeutics Corp. President 01/08/2020
Tous les postes actifs de Michael Dacks

Anciens postes connus de Michael Dacks

SociétésPosteFin
STATEHOUSE HOLDINGS INC. Director/Board Member 31/12/2021
PSYENCE GROUP INC. Chief Operating Officer 01/02/2021
Corporate Officer/Principal 01/07/2019
MEDRELEAF CORP General Counsel 02/09/2018
Midatadin.com Ltd. Founder 01/07/2016
Voir l'expérience en détail de Michael Dacks

Formation de Michael Dacks

University of Western Ontario Undergraduate Degree
Osgoode Hall Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Dacks

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
VERTICAL PEAK HOLDINGS INC.

Process Industries

STATEHOUSE HOLDINGS INC.

Process Industries

PSYENCE GROUP INC.

Industrial Services

Entreprise privées5

Health Technology

Process Industries

Midatadin.com Ltd.

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Michael Dacks